Join Us at LINC 2023

Get ready to engage in Abbott’s scientific program and hear about life-changing technologies from our panel of experts. Come and join our symposia and experience the diverse endovascular portfolio through our hands-on models.

CSI is now Abbott. We’re combining strengths to create the future of vascular care.

Visit our booths at LINC 2023 to learn more.

Scientific Sessions

Opening Symposium | June 6th | 08:00–09:15 CET | Main Arena 1

SAVING LIMBS: HOW A BROADER PAD APPROACH IMPROVES PATIENTS’ TREATMENT

Chair:
Prof. D. Scheinert
Prof. D. Scheinert
Panel:
Dr. A. Schmidt
Dr. L. Maene
Dr. M. Manzi
Dr. L. Patrone
Agenda:
  • Beyond Intervention: our most important learnings from the journey
    (Professor Dierk Scheinert)
  • BTK Live case: excellence in every step to achieve optimized results
    (Dr. Andrej Schmidt)
  • How to prevent amputation – my experience working as a multidisciplinary team
    (Dr. Lieven Maene)
  • Round table discussion
Learning objectives:
  • Focus on the most important outcomes from beyond intervention report: insights across the vascular patient journey
  • To show the patient’s impact of a diagnosis combined with optimal treatment for BTK lesions
  • To share the importance of the multidisciplinary team to prevent amputations

Symposium | June 8th | 10:15–11:00 CET | Technical Forum

INTERWOVEN NITINOL STENT: EXPERTS EXPERIENCE BEYOND THE SUPERFICIAL FEMORAL ARTERY

Chair:
Dr. K. Deloose
Dr. K. Deloose
Panel:
Dr. R. Langhoff
Dr. R. Langhoff
Dr. A. Ysa
Dr. A. Ysa
Agenda:
  • State of the art: My experience with interwoven nitinol stent
    (Dr. Ralf Langhoff)
  • Recorded case: CFA - from no go to why not?
    (Dr. August Ysa)
  • Discussion
Learning objectives:
  • To highlight the importance of learning interwoven nitinol stent: starting from easy cases then building on complexity
  • Learn the most important consideration when treating the CFA endovascularly

Lunch Symposium | June 8th | 12:30-13:15 CET | Main Arena 1

Endovascular treatment algorithms for the management of complex calcified lesions: A case based discussion

Chair:
Prof. D. Scheinert
Prof. D. Scheinert
Panel:
Dr. K. Katsanos
Dr. K. Katsanos
Dr. M. Lichtenberg
Dr. M. Lichtenberg
Agenda:
  • Opening
    (Professor Dierk Scheinert)
  • Device and mechanism of action overview
    (Dr. Michael Lichtenberg)
  • Case presentation 1
    (Dr. Konstantinos Katsanos)
  • Case presentation 2
    (Dr. Michael Lichtenberg)
  • Session key learnings and close
    (Professor Dierk Scheinert)
Learning objectives:
  • Increase understanding and confidence in the treatment of complex calcific PAD with the CSI STEALTH Orbital Atherectomy System (OAS)
  • Share real world examples and engage with expert colleagues on how to approach and treat advanced disease
  • Discuss OAS treatment algorithms for calcium, optimizing vessel preparation, OAS crown selection criteria and patient selection

Booth & Innovation

Illustration of the Abbott Booth at LINC 2023
  • Networking
    Lounge
  • Product
    Experts
  • Barista
    Zone

Join us to discover our innovative endovascular product stations and experience Supera™ Peripheral Stent deployment through Mentice™ simulator.

CSI is now Abbott. Visit our booths to learn more with hands-on.

Contact your Sales Representative to hear about opportunities for new product development testing during the congress.

Featured Products

Perclose™ ProStyle™ Suture-Mediated Closure and Repair (SMCR) System is the next generation design evolution of the proven and trusted Perclose ProGlide™ SMC System.

Supera™ Peripheral Stent is uniquely designed to keep vessels open with its distinct interwoven nitinol design that provides high structural integrity and kink resistance.

Sign Up for More News

Thank you for signing up!

Disclaimer

You are about to enter an Abbott country or region specific website.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.

Do you wish to continue and enter this website?

Yes No